Posizioni attive di Chulho Park
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | - |
| Fondatore | 01/01/2015 | - |
Storia della carriera di Chulho Park
Precedenti posizioni note di Chulho Park
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 22/04/2019 | 01/07/2021 |
| Mabprex, Inc. | Amministratore Delegato | 01/01/2010 | 01/01/2018 |
| Fondatore | 01/01/2010 | 01/01/2018 | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 01/01/2013 | 01/09/2013 |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
| Mabprex, Inc. |
- Borsa valori
- Insiders
- Chulho Park
- Esperienza